TONGLI PHARMACEUTICALS (USA), INC.: 10-Q filed 2011-11-15
What TONGLI PHARMACEUTICALS (USA), INC. reported in its quarterly report filed 2011-11-15 (fiscal Q2 2011): 30 published measures, 74 facts as tagged in accession 0001144204-11-065145.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-15
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001144204-11-065145 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TONGLI PHARMACEUTICALS (USA), INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 20,300,719 | USD | |
| At 2011-03-31 | 17,866,772 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 18,193,610 | USD | |
| At 2011-03-31 | 15,003,938 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 337,363 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 1,937,671 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 346,274 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 1,284,924 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -1,457,337 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 583,959 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -201,127 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 58,915 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 1,088,744 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 7,194,762 | USD | |
| At 2011-03-31 | 5,257,091 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 399,789 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 980,364 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 220,214 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 552,000 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 6,372,323 | USD | |
| At 2011-03-31 | 6,383,717 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 773,500 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 97,500 | USD | 183 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 751,372 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 2,946,188 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 581,030 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 1,865,370 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 6,335,299 | USD | |
| At 2011-03-31 | 3,978,646 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,206,038 | USD | |
| At 2011-03-31 | 1,790,763 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 637,521 | USD | |
| At 2011-03-31 | 756,355 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 4,003,000 | USD | |
| At 2011-03-31 | 2,060,773 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,043,622 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 1,417,198 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 400,503 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 539,441 | USD | 183 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 2,111,428 | USD | |
| At 2011-03-31 | 194,052 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 1,794,994 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 4,363,386 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 981,533 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 2,404,811 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 13,168,778 | shares | |
| At 2011-03-31 | 11,663,207 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 8,803,025 | USD | |
| At 2011-03-31 | 8,031,031 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 2,182,654 | USD | |
| At 2011-03-31 | 1,704,153 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 180,149 | USD | |
| At 2011-03-31 | 199,474 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 573,172 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 2,416,172 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 510,757 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 1,528,896 | USD | 183 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 918,107 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 1,135,130 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 343,729 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 430,809 | USD | 183 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 174,452 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 182,599 | USD | 183 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -14,220 | USD | 92 |
| 2011-04-01 to 2011-09-30 | -28,153 | USD | 183 |
| 2010-07-01 to 2010-09-30 | -14,542 | USD | 92 |
| 2010-04-01 to 2010-09-30 | -28,446 | USD | 183 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -2,805 | USD | 183 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 1,867,914 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 433,301 | USD | 183 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 1,890,848 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 117,202 | USD | 183 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -138,858 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 17,487 | USD | 183 |
Inspect the source
- Entity
- TONGLI PHARMACEUTICALS (USA), INC. / CIK 0001052284
- Captured
- SEC response SHA-256
cecbc5501de9187b88864fce4f9988916aa157e54132bd604a9d0b3d020861a9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001052284.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))